Dipl.-Biol. Siegfried J.W. Ruppert

U.S. Attorney | U.S. Patent Attorney

U.S. Patents for Clients

While working as a patent agent and patent attorney at prominent U.S. law firms, Dr. Ruppert worked on a wide variety of patents in life sciences, UV technologies, and other scientific fields for institutional clients, U.S. companies, including U.S. start-up companies, and for the U.S. government (National Institutes of Health). Here is a representative listing of U.S. patents Dr. Ruppert worked on:

  • U.S. Patent Nr. 10,184,933; Title: “Compositions, systems and methods for gene expression noise drug screening and uses thereof”
  • U.S. Patent Nr. 10,155,041; Title: “Bacterial phospholipase inhibitors as modulators of colonic bacterial flora”
  • U.S. Patent Nr. 10,046,073; Title: “Portable UV devices, systems and methods of use and manufacturing”
  • U.S. Patent Nr. 9,956,260; Title: “Treatment of HIV-1 Infection and AIDS”
  • U.S. Patent Nr. 9,707,306; Title: “UV sterilization of containers”
  • U.S. Patent Nr. 9,687,575; Title: “UV devices, systems and methods for UV sterilization”
  • U.S. Patent Nr. 9,682,161; Title: “Compositions and methods for UV sterilization”
  • U.S. Patent Nr. 9,598,456; Title: “Modified cytosine polynucleotide oligomers and methods”
  • U.S. Patent Nr. 9,598,455; Title: “Modified thymine polynucleotide oligomers and methods”
  • U.S. Patent Nr. 9,387,268; Title: “Compositions and methods for UV sterilization”
  • U.S. Patent No. 9,352,010; Title: “Treatment of HIV-1 Infection and AIDS”
  • U.S. Patent Nr. 9,328,391; Title: “Cloning and expression of HIV-1 DNA”
  • U.S. Patent Nr. 9,321,730; Title: “Method of making and administering quinoline derivatives as anti-cancer agents”
  • U.S. Patent Nr. 9,309,574; Title: “Molecular cloning of HIV-1 from immortalized cell lines”
  • U.S. Patent Nr. 9,138,669; Title: “Multilayer nanofiber filter”
  • U.S. Patent Nr. 9,089,288; Title: “Apparatus and method for non-invasive diabetic retinopathy detection and monitoring”
  • U.S. Patent Nr. 9,044,521; Title: “UV sterilization of containers”
  • U.S. Patent Nr. 9,017,266; Title: “Automated testing for palpating diabetic foot patient”
  • U.S. Patent Nr. 8,993,065; Title: “Substrate coating with aqueous-based multifunctional core shell particles”
  • U.S. Patent Nr. 8,916,583; Title: “Therapeutic compositions for intranasal administration of Zolpidem”
  • U.S. Patent Nr. 8,901,292; Title: “Method of mass production of tetrakis(p-nitrophenyl)-porphyrins”
  • U.S. Patent Nr. 8,871,159; Title: “Preparation of cells, cell aggregates and tissue fragments”
  • U.S. Patent Nr. 8,785,609; Title: Cloning and expression of HTLV-III [HIV-1] DNA”
  • U.S. Patent Nr. 8,709,732; Title: “Biomarkers of gastric cancer and uses thereof”
  • U.S. Patent Nr. 8,669,354; Title: “Removal of endotoxin using amphiphilic core-shell nanosorbents”
  • U.S. Patent Nr. 8,544,252; Title: “Method and apparatus for reducing residual torque and neps in singles ring yarns”
  • U.S. Patent Nr. 8,523,971; Title: “Multilayer nanofiber filters”
  • U.S. Patent Nr. 8,399,029; Title: “Influenza prevention and treatment compositions”
  • U.S. Patent Nr. 8,349,299; Title: “Conditioning agent and a method for making hair having a shape memory effect”
  • U.S. Patent Nr. 8,344,007; Title: “Water-soluble polymer-based canthararimides as potentially selective anti-tumor agents”
  • U.S. Patent Nr. 8,338,180; Title: “Methods for treating lentivirus infections”
  • U.S. Patent Nr. 8,329,425; Title: “Method and system for detection of chloramphenicol”
  • U.S. Patent Nr. 8,318,922; Title: “Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins”
  • U.S. Patent Nr. 7,993,647; Title: “Monoclonal antibodies to HIV-1 and methods of using same”
  • U.S. Patent Nr. 7,815,916; Title: “Cloning and expression of HTLV-III [HIV-1] DNA”
  • U.S. Patent Nr. 7,754,861; Title: “Method for purifying proteins”
  • U.S. Patent Nr. 7,723,021; Title: “Methods for treating lentivirus infections”
  • U.S. Patent Nr. 7,645,449; Title: “Sensitizing cells for apoptosis by selectively blocking cytokines”
  • U.S. Patent Nr. 6,927,028; Title: “Noninvasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA”

In addition, for obtaining international patent protection for his clients, Dr. Ruppert works (worked) with foreign patent law firms, among others, in Australia, Canada, China, Europe, India, Japan, Mexico, Taiwan, South Africa, and Vietnam.